As a company striving to build a healthy and sustainable world by optimizing decisions, N-SIDE rallied its employees to take part in a collaborative challenge while having a positive impact on the environment. A three-way collaboration In order to support our corporate social responsibility while actively involving our employees, we recently launched the “N-SIDE Care […]

Anticipating the future is a key concern for all actors of the energy sector. More specifically, as energy became a data-driven sector, forecasting of time-series has taken a significant importance for a wide range of actors: for a system operator to minimise the operational costs of running the grid for an asset owner to support […]

Following N-SIDE’s collaboration with CO2logic last year, we determined that the main source of our CO2 emissions was coming from our mobility. Consequently, N-SIDE decided to make the reduction of CO2 emissions a top priority. As a first step, back in November 2019, we offered a sustainable mobility alternative to our employees: the usage of […]

One of the most challenging elements in clinical trial supply management is planning correctly for buffer stock or overage. Since randomized clinical trials are inherently uncertain when it comes to patient demand, buffer stock is necessary to ensure that the right medications are on-site for patient dispensing. However, when buffers are not consumed within the […]

Commitment and collaboration are two of N-SIDE’s core values, which has been put in evidence by our most recent contribution to the startup aSmartWorld. In the framework of our past efforts into raising our employee’s awareness about companies that create a positive impact, our goal is to involve each employee in collaborating towards sustainability and […]

  N-SIDE is very pleased to announce that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. With this new agreement, UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to optimize the supply management from protocol design to on-going clinical trials. Philippe Verlaine, Head of […]